These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33022587)

  • 21. [Evaluation of 2 invasive techniques for treating myofascial pain].
    Corujeira Rivera MC; Carregal Rañó A; Diz Gómez JC; Mayo Moldes M; Prieto Requeijo P; Areán González I
    Rev Esp Anestesiol Reanim; 2010 Feb; 57(2):86-90. PubMed ID: 20336999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in the quality of life in patients with multiple sclerosis treated with ocrelizumab].
    Boyko OV; Choroshilova II; Petrov SV; Melnikov MV; Boyko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10. Vyp. 2):120-127. PubMed ID: 31934997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in symptoms of depression between females and males with relapsing-remitting multiple sclerosis.
    Mayo CD; Lacey C; Gawryluk JR;
    Mult Scler Relat Disord; 2021 Jun; 51():102884. PubMed ID: 33799287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
    Affaitati G; Fabrizio A; Savini A; Lerza R; Tafuri E; Costantini R; Lapenna D; Giamberardino MA
    Clin Ther; 2009 Apr; 31(4):705-20. PubMed ID: 19446144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teriflunomide for multiple sclerosis.
    He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement in clinical outcomes after dry needling versus myofascial release on pain pressure thresholds, quality of life, fatigue, pain intensity, quality of sleep, anxiety, and depression in patients with fibromyalgia syndrome.
    Castro Sánchez AM; García López H; Fernández Sánchez M; Pérez Mármol JM; Aguilar-Ferrándiz ME; Luque Suárez A; Matarán Peñarrocha GA
    Disabil Rehabil; 2019 Sep; 41(19):2235-2246. PubMed ID: 29681188
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
    Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y
    Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramuscular and nerve root stimulation vs lidocaine injection to trigger points in myofascial pain syndrome.
    Ga H; Koh HJ; Choi JH; Kim CH
    J Rehabil Med; 2007 May; 39(5):374-8. PubMed ID: 17549328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology and Management of Abdominal Myofascial Pain Syndrome (AMPS): A Three-Year Prospective Audit of a Management Pathway in 120 Patients.
    Niraj G
    Pain Med; 2018 Nov; 19(11):2256-2266. PubMed ID: 29444277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Efficiency of Ultrasound-Guided Injections of the Rhomboid Major and Trapezius Muscles in Myofascial Pain Syndrome: A Prospective Randomized Controlled Double-blind Study.
    Metin Ökmen B; Ökmen K; Altan L
    J Ultrasound Med; 2018 May; 37(5):1151-1157. PubMed ID: 29048132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic ultrasound versus injection of local anesthetic in the treatment of women with chronic pelvic pain secondary to abdominal myofascial syndrome: a randomized clinical trial.
    Baltazar MCDV; Russo JAO; De Lucca V; Mitidieri AMS; da Silva APM; Gurian MBF; Poli-Neto OB; Rosa-E-Silva JC
    BMC Womens Health; 2022 Aug; 22(1):325. PubMed ID: 35918696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of glatiramer acetate on spasticity in previously interferon-beta-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: a prospective, nonrandomized, open-label, uncontrolled, observational pilot study.
    Meca-Lallana JE; de Mingo-Casado P; Amorin-Díaz M; Martínez-Navarro ML; Barreiro AF
    Clin Ther; 2010 Jun; 32(6):1061-6. PubMed ID: 20637960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of depression and fatigue on relapsing remitting multiple sclerosis in Kingdom of Saudi Arabia.
    Alshamrani FJ; Almuaigel MF; Alkhamis FA; Alsulaiman AA; AlMohish NM; Albuhassah AF; AlZahrani AS; Mahmoud Zaher AA
    Saudi Med J; 2020 Mar; 41(3):290-295. PubMed ID: 32114602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome.
    Sandi D; Biernacki T; Szekeres D; Füvesi J; Kincses ZT; Rózsa C; Mátyás K; Kása K; Matolcsi J; Zboznovits D; Burány Z; Langane É; Vécsei L; Bencsik K
    Mult Scler Relat Disord; 2017 Oct; 17():57-62. PubMed ID: 29055476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trigger point injections for myofascial pain during epidural analgesia for labor.
    Tsen LC; Camann WR
    Reg Anesth; 1997; 22(5):466-8. PubMed ID: 9338910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Water-diluted local anesthetic for trigger-point injection in chronic myofascial pain syndrome: evaluation of types of local anesthetic and concentrations in water.
    Iwama H; Ohmori S; Kaneko T; Watanabe K
    Reg Anesth Pain Med; 2001; 26(4):333-6. PubMed ID: 11464352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of myofascial trigger point injections on nocturnal calf cramps.
    Kim DH; Yoon DM; Yoon KB
    J Am Board Fam Med; 2015; 28(1):21-7. PubMed ID: 25567819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duloxetine for the treatment of overactive bladder syndrome in multiple sclerosis: a pilot study.
    Di Rezze S; Frasca V; Inghilleri M; Durastanti V; Cortese A; Giacomelli E; Millefiorini E
    Clin Neuropharmacol; 2012; 35(5):231-4. PubMed ID: 22751087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life in patients with multiple sclerosis and their caregivers in Colombia: One-year follow-up.
    Beltrán E; Díaz D; Díaz C; Zarco L
    Biomedica; 2020 Mar; 40(1):129-136. PubMed ID: 32220169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.